Working together to shape the endometrial cancer research agenda: The top ten unanswered research questions
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Endometrial cancer (EC) is the most common gynaecological cancer in developed nations and its incidence is rising. As a direct consequence, more women are dying from EC despite advances in care and improved survivorship. There is a lack of research activity and funding, as well as public awareness about EC. We sought to engage patients, carers and healthcare professionals to identify the most important unanswered research questions in EC. METHODOLOGY: The priority setting methodology was developed by the James Lind Alliance and involved four key stages: gathering research questions; checking these against existing evidence; interim prioritisation; and a final consensus meeting during which the top ten unanswered research questions were agreed using modified nominal group methodology. RESULTS: Our first online survey yielded 786 individual submissions from 413 respondents, of whom 211 were EC survivors or carers, and from which 202 unique unanswered research questions were generated. 253 individuals, including 108 EC survivors and carers, completed an online interim prioritisation survey. The resulting top 30 questions were ranked in a final consensus meeting. Our top ten spanned the breadth of patient experience of this disease and included developing personalised risk scoring, refining criteria for specialist referral, understanding the underlying biology of different types of EC, developing novel personalised treatment and prevention strategies, prognostic and predictive biomarkers, increasing public awareness and interventions for psychological issues. CONCLUSION: Having established the top ten unanswered research questions in EC, we hope this galvanises researchers, healthcare professionals and the public to collaborate, coordinate and invest in research to improve the lives of women affected by EC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0155 · Cited by 7,094
Qualitative Research: Consensus methods for medical and health services research
Jones, J., & Hunter, D. (1995) · BMJ · doi:10.1136/bmj.311.7001.376 · Cited by 3,471
Shafir, E. (1993) · Cognition · doi:10.1016/0010-0277(93)90034-s · Cited by 1,453 · cited 1×
“Decision making research has shown that increasing the number of alternatives increases the complexity of the decision, leading to increasing conflict and forcing individuals to resort to deferring decisions, choosing the default option or failing tomake a decision altogether [18,19].”
BackgroundHow to increase value and reduce waste when research priorities are set
Chalmers, I., Bracken, M. B., Djulbegovic, B., Garattini, S., Grant, J., Gülmezoglu, A. M., Howells, D. W., Ioannidis, J. P. A., & Oliver, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62229-1 · Cited by 1,436
Cited by
Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21763 · Cited by 16,303
Siegel, R. L., Giaquinto, A. N., & Jemal, A. (2024) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21820 · Cited by 9,533
“91 The magnitude of underfunding is further increased in studies using lethality score ranking to account for disparities 92 ‐ 94 ; the 5 ‐ year relative survival rate is just 63% among Black women versus 84% among White women (Table 6).”
BackgroundCrosbie, E. J., Kitson, S. J., McAlpine, J. N., Mukhopadhyay, A., Powell, M. E., & Singh, N. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00323-3 · Cited by 1,333
Self-citationPembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
Eskander, R. N., Sill, M. W., Beffa, L., Moore, R. G., Hope, J. M., Musa, F. B., Mannel, R., Shahin, M. S., Cantuaria, G. H., Girda, E., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2302312 · Cited by 758
Self-citationPrior, M., Bagness, C., Brewin, J., Coomarasamy, A., Easthope, L., Hepworth-Jones, B., Hinshaw, K., O'Toole, E., Orford, J., Regan, L., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016571 · Cited by 56
Metadata
- Authors
- Wan, Y. L., Beverley-Stevenson, R., Carlisle, D., Clarke, S., Edmondson, R. J., Glover, S., Holland, J., Hughes, C., Kitchener, H. C., Kitson, S., Miles, T., Morley, R., Morrison, J., Nelson, L., Powell, M., Sadler, L., Tomlinson, A., Tylko-Hill, K., Whitcombe, J., & Crosbie, E. J.
- Venue
- Gynecologic Oncology
- Publisher
- Elsevier BV
- Published
- 2016-11
- Volume
- 143
- Issue
- 2
- Pages
- 287-293
- ISSN
- 0090-8258 (ISSN-L)
- OpenAlex
- W2518381736
- Cited by
- 107
- References
- 4
- FWCI
- 7.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Working together to shape the endometrial cancer research agenda: The top ten unanswered research questions. https://app.cochat.ai/papers/10.1016/j.ygyno.2016.08.333
- The paper
- Wan, Y. L., Beverley-Stevenson, R., Carlisle, D., Clarke, S., Edmondson, R. J., Glover, S., Holland, J., Hughes, C., Kitchener, H. C., Kitson, S., Miles, T., Morley, R., Morrison, J., Nelson, L., Powell, M., Sadler, L., Tomlinson, A., Tylko-Hill, K., Whitcombe, J., & Crosbie, E. J. (2016). Working together to shape the endometrial cancer research agenda: The top ten unanswered research questions. Gynecologic Oncology. https://doi.org/10.1016/j.ygyno.2016.08.333
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.